Birgit Schoeberl, PhD: No relevant disclosure to display
Integrating Generative AI into workflows can significantly enhance their power and efficiency. In this session, we demonstrate how Novartis’s Data42 platform accelerates human exposure prediction for novel low molecular weight drug candidates. By incorporating GenAI into our workflow, we developed "PK-Copilot". In this presentation, we will introduce PK-Copilot, share our learnings and novel scientific insights.
